Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon induced transmembrane protein 1 pseudogene (ENSG00000228112) is a processed pseudogene derived from IFITM1, a member of the interferon-inducible transmembrane protein family that plays a role in antiviral immunity. Unlike the protein-encoding IFITM1 gene, this pseudogene does not produce a functional transmembrane protein but may, like other pseudogenes, have rare regulatory functions through transcription of noncoding RNAs. The functional IFITM1 protein restricts the entry of diverse viral pathogens into host cells, but its pseudogene derivative is considered "nonfunctional DNA" unless specific regulatory RNA roles are demonstrated.
None. Since this gene is non-coding, there are no known mechanisms of drug action involving it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon induced transmembrane protein 1 pseudogene (IFITM1 pseudogene).